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ABSTRACT
The activity of the p53 tumor-suppressor protein has a key role in controlling both cancer and aging: under activity encourages the growth of cancer, and over
activity can accelerate the aging process. The p53 protein is a tumor suppressor encoded by a gene whose disruption is associated with approximately 50 to 55
percent of human cancers. The p53 protein acts as a checkpoint in the cell cycle, either preventing or initiating programmed cell death (Apoptosis). p53
regulating genes MDM2,PARP, Oncogenic ras, p21 etc play crucial role in tumor suppression.
p53 mutations are common in lung cancer
and range from 33% in adenocarcinomas to
70% in small cell lung cancers. These
mutations are mostly GC to TA transversions,
with a rate of transition mutations lower
than in other cancers. A strong correlation
has been detected between the frequency of
these GC to TA transversions and lifetime
cigarette smoking. benzo(a)pyrene,a
carcinogen in tobacco is responsible for GC
to TA transversions and causes damage at
codon 157,248 and 273 in p53 gene. A large
proportion of all mutations in TP53 are single
base substitutions. Of all mutations,
approximately 30% occur in six codons (175,
245, 248, 249, 273 and 282) which are called
the hotspot codons .Thus p53 gene is target
of carcinogen found in tobacco.
RESULTS
Why do we get
cancer if tumor
suppressor is
present ?
The p53 gene has been
mapped to chromosome 17.
In the cell, p53 protein binds
DNA, which in turn
stimulates another gene to
produce a protein called p21
that interacts with a cell
division-stimulating protein
(cdk2). When p21 is
complexed with cdk2 the cell
cannot pass through to the
next stage of cell division.
Mutant p53 can no longer
bind DNA in an effective
way, and as a consequence
the p21 protein is not made
available to act as the 'stop
signal' for cell division. Thus
cells divide uncontrollably,
and form tumors.
In most tumor cells, the p53
protein is inactivated by
mutation, whereas in some
others its function is blocked
in other ways. The p53
molecule can be inactivated
in several ways. In some
human families, for
example, p53 mutations are
inherited, and family
members have a high
incidence of cancer. More
often, the molecule is
inactivated by an outside
source. DNA tumor viruses,
such as the human
adenovirus and the human
papilloma virus, can bind to
and inactivate the p53
protein function, altering
cells and initiating tumor
growth. In addition, some
sarcomas amplify another
gene, called mdm-2, which
produces a protein that
binds to p53 and inactivates
it, much the way the DNA
tumor viruses do.
DISCUSSION
INTRODUCTION
TP53 GENE and p53 PROTEIN
The tumour suppressor protein p53 was first described in 1979 and ten years later identified as a tumour
suppressor. In human, the TP53 gene that contains 11 exons is located in chromosome 17p13.1, while the mouse
gene, which also contains 11 exons, is located in chromosome 11. In both human and mouse, the coded protein
is approximately 53 kDa in size, the human protein containing 393 amino acids and mouse protein 390 amino
acids. The p53 protein consists of an acidic N-terminus with a transactivation domain, a hydrophobic central
DNA-binding core and a basic C-terminus with regulatory and oligomerisation domains. The DNA-binding domain
of the p53 protein is composed of two beta-sheets and a zinc atom which stabilizes the structure .
REGULATORY   PROTEIN
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Following P53 databases were downloaded from the website.
->p53 mutations in tumors only
->p53 mutations in cell lines
->Germline p53 mutations
Using the mutation data in the website, statistical calculations were performed using the SPSS (Statistical
Package for the Social Sciences) software. The Microsoft excel software was used to distribute the data to gain
the insight for mutations at all the codon sites on the p53 gene. The frequencies of all the 393 codons were
tabulated.
METHOD
Poly(ADP-ribose)polymerase :
Poly (ADP-ribose) polymerase (PARP) has long been known to play a role in the recognition of DNA damage
and in DNA repair. The PARP protein detects DNA strand breaks and catalyzes the attachment of ADP-ribose
units from NAD to itself and to other proteins. The substrates of PARP can then influenze the architecture of
chromatin or act inDNA metabolism. PARPplays a positive role in the activation and upregulationof p53.
KEYWORDS: Apoptosis, p53, p21, MDM2, tumor-suppressor.
MODE OF ACTION OF P53:
The tumor-suppressing p53 protein (left) can bind to target sequences 
on the DNA double helix to activate genes that prevent cell growth.
Mdm2 PROTEIN
The murine double minute 2 (mdm2,
hdm2 in human) gene encodes a 90 kDa
protein (97 kDa in human) ,a dominant
transforming oncogene. The mdm2 gene
has been found to be amplified in human
cancers. The combination of over
expressed mdm2 and p53 gives a worse
prognosis than either one of them alone.
Deletion of the mdm2 gene in mice is
embryonically lethal, probably due to
increased accumulation of p53, but this
lethality can be counter-acted by deletion
of the TP53 gene. The p53-mdm2
relationship is vital in the regulation of
cell growth and death.
PROTEIN INVOLVED IN THE REGULATION OF 
THE DNA DAMAGE - INDUCED  p53 PROTEIN. 
Oncogenic Ras :
Mammalian ras genes are considered crucial in the regulation of cell proliferation. In
mammals, the ras family consists of three genes located in different chromosomes,
encoding the homologous 21 kDa proteins H-Ras, N-Ras and K-Ras. It has been estimated
that 30% of all human cancers express mutated forms of ras. Ras regulates MAPK which in
turn regulates p53.. Ras induces p19ARF in murine fibroblasts.
p21 :
p21 play role in the inhibition of CDK-cyclin activity and directly inhibit DNA replication. The gene is
transcriptionally upregulated by wild-type p53 .The activation of p53 causes induction of p21, which in turn
inhibits CDK-cyclin activity and arrests the cell cycle at the G1 or G2 cell cycle checkpoint. This gives time for
DNA repair before replication or mitosis and thus links p21 directly to the tumour suppressor function of
p53.
THE p53 PATHWAY
FUNCTIONS
 Inhibition of cell growth i.e. APOPTOSIS.
Transcrptional activation of cell cycle gene.
Induction of cell arrest of cell.
Preventing the fixation of of damaged DNA as mutation.
Aberrations of p53 function
There are many ways in which the p53 function may be altered in human
cancers.
p53 can be inactivated indirectly through binding to viral proteins, as a
result of alterations in the mdm2 or p19ARF genes or by localization of the
p53 protein to the cytoplasm.
Other factors that prevent normal folding of the p53 protein, such as
cadmium, may influence its DNA-binding capacity.
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